{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:55:18Z","timestamp":1792803318237,"version":"4.5.0"},"reference-count":44,"publisher":"National Academy of Sciences","issue":"27","license":[{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":183,"URL":"http:\/\/www.pnas.org\/preview_site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["KAKENHI #26293087"],"award-info":[{"award-number":["KAKENHI #26293087"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2016,7,5]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Fibrosis is a leading cause of death in industrialized countries. Until now, there has been no effective therapy to prevent or counteract the fibrotic process. This article describes the effect of the blockade of a late costimulatory molecule to prevent inflammation-driven skin, lung, and vessel fibrosis and to induce regression of established dermal fibrosis in vivo in complementary murine models of systemic sclerosis, a prototypic autoimmune fibrotic disease. This article also reveals an unexpected role of this protein as a biomarker of worsening fibrosis that might help delineate the prognosis of patients in clinical practice more accurately.<\/jats:p>","DOI":"10.1073\/pnas.1523512113","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T23:05:39Z","timestamp":1465859139000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":77,"title":["OX40L blockade protects against inflammation-driven fibrosis"],"prefix":"10.1073","volume":"113","author":[{"given":"Muriel","family":"Elhai","sequence":"first","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"},{"name":"Rheumatology A Department, Cochin Hospital, Paris Descartes University, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"},{"name":"Rheumatology A Department, Cochin Hospital, Paris Descartes University, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Hoffmann-Vold","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Oslo University Hospital, 0873 Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Ruzehaji","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Amiar","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ruiz","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassina","family":"Brahiti","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Ponsoye","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Fr\u00e9chet","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Burgevin","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Pezet","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Sadoine","sequence":"additional","affiliation":[{"name":"Equipe d\u2019Accueil (EA) 2496 Pathologie, Imagerie et Bioth\u00e9rapies Orofaciales, Faculty of Odontology, Paris Descartes University, Sorbonne Paris Cite, 92120 Montrouge, France;"},{"name":"Plateforme d\u2019Imagerie Du Vivant, Le P\u00f4le de Recherche et d\u2019Enseignement Sup\u00e9rieur Sorbonne Paris Cit\u00e9, 92120 Montrouge, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Guilbert","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Nicco","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaya","family":"Akiba","sequence":"additional","affiliation":[{"name":"Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vigo","family":"Heissmeyer","sequence":"additional","affiliation":[{"name":"Research Unit Molecular Immune Regulation, Institute of Molecular Immunology, Helmholtz Zentrum Mu\u0308nchen, DE-81377 Munich, Germany;"},{"name":"Institute for Immunology, Ludwig-Maximilians-Universit\u00e4t Mu\u0308nchen, DE-80336 Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Subramaniam","sequence":"additional","affiliation":[{"name":"Immune Mediated Diseases, Sanofi Genzyme, Framingham, MA 01701;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Resnick","sequence":"additional","affiliation":[{"name":"Immune Mediated Diseases, Sanofi Genzyme, Framingham, MA 01701;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Molberg","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Oslo University Hospital, 0873 Oslo, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Kahan","sequence":"additional","affiliation":[{"name":"Rheumatology A Department, Cochin Hospital, Paris Descartes University, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Chiocchia","sequence":"additional","affiliation":[{"name":"INSERM, U1173, Faculty of Health Sciences Simone Veil, Universit\u00e9 Versailles-Saint-Quentin, 78180 Saint-Quentin-En-Yvelines, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[{"name":"INSERM, U1016 UMR8104, Cochin Institute, Paris Descartes University, Sorbonne Paris Cite, 75014 Paris, France;"},{"name":"Rheumatology A Department, Cochin Hospital, Paris Descartes University, 75014 Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2016,6,13]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: Nearing the starting line","volume":"5","author":"Friedman SL","year":"2013","unstructured":"SL Friedman, D Sheppard, JS Duffield, S Violette, Therapy for fibrotic diseases: Nearing the starting line. Sci Transl Med 5, 167sr1 (2013).","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga J","year":"2009","unstructured":"J Varga, B Pasche, Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol 5, 200\u2013206 (2009).","journal-title":"Nat Rev Rheumatol"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nri1371","article-title":"Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40","volume":"4","author":"Sugamura K","year":"2004","unstructured":"K Sugamura, N Ishii, AD Weinberg, Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nat Rev Immunol 4, 420\u2013431 (2004).","journal-title":"Nat Rev Immunol"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0065-2776(10)05003-0","article-title":"OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology","volume":"105","author":"Ishii N","year":"2010","unstructured":"N Ishii, T Takahashi, P Soroosh, K Sugamura, OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol 105, 63\u201398 (2010).","journal-title":"Adv Immunol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","article-title":"OX40, OX40L and autoimmunity: A comprehensive review","volume":"50","author":"Webb GJ","year":"2016","unstructured":"GJ Webb, GM Hirschfield, PJL Lane, OX40, OX40L and autoimmunity: A comprehensive review. Clin Rev Allergy Immunol 50, 312\u2013332 (2016).","journal-title":"Clin Rev Allergy Immunol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/ard.2009.116434","article-title":"Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis","volume":"69","author":"Gourh P","year":"2010","unstructured":"P Gourh, , Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann Rheum Dis 69, 550\u2013555 (2010).","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/ard.2010.141838","article-title":"A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort","volume":"70","author":"Bossini-Castillo L","year":"2011","unstructured":"L Bossini-Castillo, , A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Ann Rheum Dis 70, 638\u2013641 (2011).","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3899\/jrheum.111270","article-title":"Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis","volume":"39","author":"Coustet B","year":"2012","unstructured":"B Coustet, , Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis. J Rheumatol 39, 997\u20131003 (2012).","journal-title":"J Rheumatol"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3899\/jrheum.080120","article-title":"Increased serum soluble OX40 in patients with systemic sclerosis","volume":"35","author":"Komura K","year":"2008","unstructured":"K Komura, , Increased serum soluble OX40 in patients with systemic sclerosis. J Rheumatol 35, 2359\u20132362 (2008).","journal-title":"J Rheumatol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1073\/pnas.1321071111","article-title":"OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis","volume":"111","author":"Gwyer Findlay E","year":"2014","unstructured":"E Gwyer Findlay, , OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis. Proc Natl Acad Sci USA 111, 2289\u20132294 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1002\/art.33501","article-title":"Inhibition of activator protein 1 signaling abrogates transforming growth factor \u03b2-mediated activation of fibroblasts and prevents experimental fibrosis","volume":"64","author":"Avouac J","year":"2012","unstructured":"J Avouac, , Inhibition of activator protein 1 signaling abrogates transforming growth factor \u03b2-mediated activation of fibroblasts and prevents experimental fibrosis. Arthritis Rheum 64, 1642\u20131652 (2012).","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/art.27647","article-title":"Animal models of systemic sclerosis: Prospects and limitations","volume":"62","author":"Beyer C","year":"2010","unstructured":"C Beyer, G Schett, O Distler, JHW Distler, Animal models of systemic sclerosis: Prospects and limitations. Arthritis Rheum 62, 2831\u20132844 (2010).","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_13_2","first-page":"493","article-title":"Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton","volume":"82","author":"Green MC","year":"1976","unstructured":"MC Green, HO Sweet, LE Bunker, Tight-skin, a new mutation of the mouse causing excessive growth of connective tissue and skeleton. Am J Pathol 82, 493\u2013512 (1976).","journal-title":"Am J Pathol"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall AJ","year":"2010","unstructured":"AJ Tyndall, , Causes and risk factors for death in systemic sclerosis: A study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69, 1809\u20131815 (2010).","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2011-200940","article-title":"Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis","volume":"71","author":"Maurer B","year":"2012","unstructured":"B Maurer, , Fra-2 transgenic mice as a novel model of pulmonary hypertension associated with systemic sclerosis. Ann Rheum Dis 71, 1382\u20131387 (2012).","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/CIRCULATIONAHA.109.855114","article-title":"Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis","volume":"120","author":"Maurer B","year":"2009","unstructured":"B Maurer, , Transcription factor fos-related antigen-2 induces progressive peripheral vasculopathy in mice closely resembling human systemic sclerosis. Circulation 120, 2367\u20132376 (2009).","journal-title":"Circulation"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1513\/pats.200608-152MS","article-title":"Mechanisms of scleroderma-induced lung disease","volume":"4","author":"du Bois RM","year":"2007","unstructured":"RM du Bois, Mechanisms of scleroderma-induced lung disease. Proc Am Thorac Soc 4, 434\u2013438 (2007).","journal-title":"Proc Am Thorac Soc"},{"key":"e_1_3_4_18_2","first-page":"166","article-title":"Treatment of early diffuse systemic sclerosis skin disease","volume":"31","author":"Frech TM","year":"2013","unstructured":"TM Frech, , Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol 31, 166\u2013171 (2013).","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4049\/jimmunol.162.1.486","article-title":"Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein","volume":"162","author":"Higgins LM","year":"1999","unstructured":"LM Higgins, , Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: Amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol 162, 486\u2013493 (1999).","journal-title":"J Immunol"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.4049\/jimmunol.167.5.2991","article-title":"Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis","volume":"167","author":"Ndhlovu LC","year":"2001","unstructured":"LC Ndhlovu, N Ishii, K Murata, T Sato, K Sugamura, Critical involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 167, 2991\u20132999 (2001).","journal-title":"J Immunol"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.07.001","article-title":"CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis","volume":"145","author":"Carboni S","year":"2003","unstructured":"S Carboni, , CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J Neuroimmunol 145, 1\u201311 (2003).","journal-title":"J Neuroimmunol"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","article-title":"The significance of OX40 and OX40L to T-cell biology and immune disease","volume":"229","author":"Croft M","year":"2009","unstructured":"M Croft, T So, W Duan, P Soroosh, The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev 229, 173\u2013191 (2009).","journal-title":"Immunol Rev"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.4049\/jimmunol.159.8.3838","article-title":"Expression and function of OX40 ligand on human dendritic cells","volume":"159","author":"Ohshima Y","year":"1997","unstructured":"Y Ohshima, , Expression and function of OX40 ligand on human dendritic cells. J Immunol 159, 3838\u20133848 (1997).","journal-title":"J Immunol"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.4049\/jimmunol.180.11.7240","article-title":"Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival","volume":"180","author":"Song J","year":"2008","unstructured":"J Song, T So, M Croft, Activation of NF-kappaB1 by OX40 contributes to antigen-driven T cell expansion and survival. J Immunol 180, 7240\u20137248 (2008).","journal-title":"J Immunol"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.4049\/jimmunol.163.6.3007","article-title":"Intracellular signaling of gp34, the OX40 ligand: Induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40","volume":"163","author":"Matsumura Y","year":"1999","unstructured":"Y Matsumura, T Hori, S Kawamata, A Imura, T Uchiyama, Intracellular signaling of gp34, the OX40 ligand: Induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J Immunol 163, 3007\u20133011 (1999).","journal-title":"J Immunol"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.4049\/jimmunol.169.8.4628","article-title":"Constitutive OX40\/OX40 ligand interaction induces autoimmune-like diseases","volume":"169","author":"Murata K","year":"2002","unstructured":"K Murata, , Constitutive OX40\/OX40 ligand interaction induces autoimmune-like diseases. J Immunol 169, 4628\u20134636 (2002).","journal-title":"J Immunol"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09059180.00003214","article-title":"Cellular interactions in the pathogenesis of interstitial lung diseases","volume":"24","author":"Bagnato G","year":"2015","unstructured":"G Bagnato, S Harari, Cellular interactions in the pathogenesis of interstitial lung diseases. Eur Respir Rev 24, 102\u2013114 (2015).","journal-title":"Eur Respir Rev"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2172-12-67","article-title":"Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension","volume":"12","author":"Rabieyousefi M","year":"2011","unstructured":"M Rabieyousefi, , Indispensable roles of OX40L-derived signal and epistatic genetic effect in immune-mediated pathogenesis of spontaneous pulmonary hypertension. BMC Immunol 12, 67 (2011).","journal-title":"BMC Immunol"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/cea.12235","article-title":"OX40L blockade and allergen-induced airway responses in subjects with mild asthma","volume":"44","author":"Gauvreau GM","year":"2014","unstructured":"GM Gauvreau, , OX40L blockade and allergen-induced airway responses in subjects with mild asthma. Clin Exp Allergy 44, 29\u201337 (2014).","journal-title":"Clin Exp Allergy"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1084\/jem.20030351","article-title":"A critical role for OX40 in T cell-mediated immunopathology during lung viral infection","volume":"198","author":"Humphreys IR","year":"2003","unstructured":"IR Humphreys, , A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J Exp Med 198, 1237\u20131242 (2003).","journal-title":"J Exp Med"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","article-title":"Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis","volume":"67","author":"Hoffmann-Vold A-M","year":"2015","unstructured":"A-M Hoffmann-Vold, , Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis. Arthritis Rheumatol 67, 2205\u20132212 (2015).","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","article-title":"Animal model of systemic sclerosis","volume":"37","author":"Yamamoto T","year":"2010","unstructured":"T Yamamoto, Animal model of systemic sclerosis. J Dermatol 37, 26\u201341 (2010).","journal-title":"J Dermatol"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/annrheumdis-2012-201759","article-title":"Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis","volume":"72","author":"Avouac J","year":"2013","unstructured":"J Avouac, , Critical role of the adhesion receptor DNAX accessory molecule-1 (DNAM-1) in the development of inflammation-driven dermal fibrosis in a mouse model of systemic sclerosis. Ann Rheum Dis 72, 1089\u20131098 (2013).","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1002\/art.34354","article-title":"Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor \u03b2 in the skin of mice with scleroderma-like features and prevents the development of the disease","volume":"64","author":"Kavian N","year":"2012","unstructured":"N Kavian, , Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor \u03b2 in the skin of mice with scleroderma-like features and prevents the development of the disease. Arthritis Rheum 64, 1990\u20132000 (2012).","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/art.30171","article-title":"Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis","volume":"63","author":"Avouac J","year":"2011","unstructured":"J Avouac, , Inactivation of the transcription factor STAT-4 prevents inflammation-driven fibrosis in animal models of systemic sclerosis. Arthritis Rheum 63, 800\u2013809 (2011).","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.1780210407","article-title":"Comparison of gold levels and distribution in guinea pig serum","volume":"21","author":"Kamel H","year":"1978","unstructured":"H Kamel, , Comparison of gold levels and distribution in guinea pig serum. Arthritis Rheum 21, 441\u2013446 (1978).","journal-title":"Arthritis Rheum"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft T","year":"1988","unstructured":"T Ashcroft, JM Simpson, V Timbrell, Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 41, 467\u2013470 (1988).","journal-title":"J Clin Pathol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2009.12.009","article-title":"Fibrillar collagen scoring by second harmonic microscopy: A new tool in the assessment of liver fibrosis","volume":"52","author":"Gailhouste L","year":"2010","unstructured":"L Gailhouste, , Fibrillar collagen scoring by second harmonic microscopy: A new tool in the assessment of liver fibrosis. J Hepatol 52, 398\u2013406 (2010).","journal-title":"J Hepatol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","unstructured":"Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581\u2013590.","DOI":"10.1002\/art.1780230510"},{"key":"e_1_3_4_40_2","first-page":"202","article-title":"Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis","volume":"15","author":"LeRoy EC","year":"1988","unstructured":"EC LeRoy, , Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15, 202\u2013205 (1988).","journal-title":"J Rheumatol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2009.04.013","article-title":"The 4th world symposium on pulmonary hypertension","volume":"54","author":"Humbert M","year":"2009","unstructured":"M Humbert, VV McLaughlin, The 4th world symposium on pulmonary hypertension. J Am Coll Cardiol 54, S1\u2013117 (2009).","journal-title":"J Am Coll Cardiol"},{"key":"e_1_3_4_42_2","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements PJ","year":"1993","unstructured":"PJ Clements, , Skin thickness score in systemic sclerosis: An assessment of interobserver variability in 3 independent studies. J Rheumatol 20, 1892\u20131896 (1993).","journal-title":"J Rheumatol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3899\/jrheum.140047","article-title":"Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease","volume":"42","author":"Hoffmann-Vold A-M","year":"2015","unstructured":"A-M Hoffmann-Vold, R Gunnarsson, T Garen, \u00d8 Midtvedt, \u00d8 Molberg, Performance of the 2013 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 42, 60\u201363 (2015).","journal-title":"J Rheumatol"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: A simple staging system","volume":"177","author":"Goh NSL","year":"2008","unstructured":"NSL Goh, , Interstitial lung disease in systemic sclerosis: A simple staging system. Am J Respir Crit Care Med 177, 1248\u20131254 (2008).","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1523512113","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1523512113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T17:51:02Z","timestamp":1692381062000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1523512113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,13]]},"references-count":44,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2016,7,5]]}},"alternative-id":["10.1073\/pnas.1523512113"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1523512113","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,13]]},"assertion":[{"value":"2016-06-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}